StonvexLoading…
StonvexStonvexStonvexCore line items from RNGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $546.90M | $571.10M | $636.60M | $608.50M |
Operating Income | $15.40M | $28.60M | $36.90M | $19.70M |
Net Income | $12.30M | $18.40M | $23.80M | $15.10M |
EPS (Diluted) | $0.54 | $0.81 | $0.95 | $0.65 |
Total Assets | $419.30M | $381.60M | $378.00M | $381.60M |
Total Liabilities | $119.20M | $107.80M | $106.20M | $115.40M |
Cash & Equivalents | $10.30M | $40.90M | $15.70M | $3.70M |
Free Cash Flow OCF − CapEx | $42.90M | $50.40M | $54.30M | $30.70M |
Shares Outstanding | 22.68M | 22.85M | 24.99M | 23.37M |